US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 1.800
- -0.010-0.55%
Close Dec 20 16:00 ET
- 1.830
- +0.030+1.67%
Post 20:01 ET
162.99MMarket Cap-1.08P/E (TTM)
1.860High1.755Low1.99MVolume1.780Open1.810Pre Close3.60MTurnover2.45%Turnover RatioLossP/E (Static)90.55MShares8.33052wk High0.58P/B146.84MFloat Cap1.50052wk Low--Dividend TTM81.58MShs Float32.645Historical High--Div YieldTTM5.80%Amplitude1.500Historical Low1.803Avg Price1Lot Size
Caribou Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.45%-32.66M | -116.44%-32.87M | -33.16%-37.2M | -2.56%-93.29M | 14.63%-21.38M | -28.66%-28.79M | 30.58%-15.19M | -28.91%-27.94M | -179.73%-90.97M | -17.09%-25.04M |
| Net income from continuing operations | -246.77%-34.68M | -27.70%-37.7M | -47.03%-41.23M | -2.66%-102.07M | -27.85%-34.51M | 62.46%-10M | -10.57%-29.52M | -46.92%-28.04M | -48.56%-99.42M | -46.05%-26.99M |
| Operating gains losses | ---- | ---- | ---- | ---34K | --0 | --0 | --0 | ---34K | ---- | ---- |
| Depreciation and amortization | -25.46%1.18M | 38.74%856K | 20.54%710K | 117.32%3.53M | 46.25%740K | 250.89%1.58M | 72.35%617K | 91.23%589K | 64.84%1.62M | 85.35%506K |
| Other non cash items | 21.02%806K | -1,744.97%-2.78M | 561.92%1.72M | 21,933.33%3.28M | 415.48%2.18M | -70.12%666K | 151.37%169K | 121.24%260K | -100.62%-15K | 67.98%-691K |
| Change In working capital | 87.20%-2.82M | -76.33%2.86M | 64.06%-849K | -74.07%-7.32M | 4,025.00%5.02M | -3,021.50%-22.07M | 595.17%12.09M | 53.76%-2.36M | -114.46%-4.2M | 95.18%-128K |
| -Change in receivables | 118.15%253K | -36.64%697K | 236.87%245K | -76.73%805K | 284.94%1.28M | -294.42%-1.39M | 238.46%1.1M | -108.58%-179K | 216.77%3.46M | 198.52%332K |
| -Change in prepaid assets | 82.31%-266K | 9.36%596K | -141.86%-758K | 281.13%1.77M | 43.26%914K | -18.80%-1.5M | -42.57%545K | 239.74%1.81M | 75.88%-975K | 149.69%638K |
| -Change in payables and accrued expense | -52.67%1.1M | -38.80%2.6M | 119.58%516K | 1,084.64%7.56M | 306.85%3.63M | 197.82%2.33M | 84.17%4.25M | 44.46%-2.64M | -114.17%-768K | 414.84%891K |
| -Change in other current assets | -1,983.89%-3.11M | 178.95%159K | -437.10%-209K | 91.49%-48K | 91.13%-18K | -325.71%-149K | -64.60%57K | 112.73%62K | -78.48%-564K | -23.03%-203K |
| -Change in other current liabilities | -167.73%-149K | -96.28%-369K | 115.79%51K | -52.39%-637K | -179.03%-346K | 326.80%220K | -80.77%-188K | -247.31%-323K | -158.02%-418K | 11.43%-124K |
| -Change in other working capital | 96.95%-658K | -112.97%-821K | 36.74%-694K | -239.46%-16.77M | 74.19%-429K | -2,572.61%-21.57M | 433.40%6.33M | -91.78%-1.1M | -115.87%-4.94M | -271.81%-1.66M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.45%-32.66M | -116.44%-32.87M | -33.16%-37.2M | -2.56%-93.29M | 14.63%-21.38M | -28.66%-28.79M | 30.58%-15.19M | -28.91%-27.94M | -179.73%-90.97M | -17.09%-25.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 138.73%26.52M | 91.61%21.2M | 10.88%22.96M | 26.88%-68.18M | -2,790.09%-31.47M | -721.15%-68.48M | 179.18%11.06M | 128.71%20.7M | 47.14%-93.25M | 100.67%1.17M |
| Net PPE purchase and sale | 51.64%-2.3M | 12.22%-2.24M | 28.71%-1.45M | -79.93%-11.61M | -29.60%-2.28M | -250.96%-4.75M | 2.56%-2.55M | -180.91%-2.03M | -204.29%-6.45M | -156.50%-1.76M |
| Net intangibles purchase and sale | ---- | ---125K | ---1.5M | --0 | ---- | ---- | --0 | --0 | 40.00%-600K | ---300K |
| Net investment purchase and sale | 142.67%27.19M | 73.06%23.57M | 13.94%25.9M | 34.37%-56.57M | -1,004.77%-29.2M | -853.24%-63.72M | 219.94%13.62M | 131.85%22.73M | 50.26%-86.2M | 101.86%3.23M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 138.73%26.52M | 91.61%21.2M | 10.88%22.96M | 26.88%-68.18M | -2,790.09%-31.47M | -721.15%-68.48M | 179.18%11.06M | 128.71%20.7M | 47.14%-93.25M | 100.67%1.17M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.82%244K | -99.25%132K | 660.35%12.49M | 7,133.85%154.3M | -133.86%-43K | 20,561.77%135.13M | 4,753.87%17.57M | 65.86%1.64M | -99.51%2.13M | -72.39%127K |
| Net common stock issuance | -99.82%244K | -96.14%669K | 908.82%11.33M | --152.72M | ---113K | --134.38M | --17.34M | --1.12M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | -327.54%-537K | 122.74%1.16M | -26.02%1.58M | -44.88%70K | 15.14%753K | -34.81%236K | -47.58%519K | -16.39%2.13M | -72.39%127K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.82%244K | -99.25%132K | 660.35%12.49M | 7,133.85%154.3M | -133.86%-43K | 20,561.77%135.13M | 4,753.87%17.57M | 65.86%1.64M | -99.51%2.13M | -72.39%127K |
| Net cash flow | ||||||||||
| Beginning cash position | -42.77%37.91M | -6.33%49.45M | -12.29%51.21M | -75.72%58.38M | 26.75%104.1M | -40.96%66.24M | -64.25%52.79M | -75.72%58.38M | 1,407.34%240.47M | -81.13%82.13M |
| Current changes in cash | -115.57%-5.9M | -185.75%-11.53M | 68.50%-1.76M | 96.06%-7.18M | -122.75%-52.9M | 225.96%37.86M | 137.90%13.45M | 93.97%-5.59M | -181.10%-182.08M | 87.82%-23.75M |
| End cash Position | -69.25%32.02M | -42.77%37.91M | -6.33%49.45M | -12.29%51.21M | -12.29%51.21M | 26.75%104.1M | -40.96%66.24M | -64.25%52.79M | -75.72%58.38M | -75.72%58.38M |
| Free cash flow | 0.61%-33.33M | -98.62%-35.23M | -33.97%-40.15M | -7.02%-104.9M | 12.71%-23.66M | -39.58%-33.54M | 27.58%-17.74M | -33.82%-29.97M | -175.03%-98.02M | -22.77%-27.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
